Get started
000

HANALL BIOPHARMA CO.,LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

009420 chart


Full chart

Key stats


Market capitalization
‪1.96 T‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−100 KRW
Net income (FY)
‪3.51 B‬ KRW
Revenue (FY)
‪134.91 B‬ KRW
Shares float
‪29.75 M‬
Beta (1Y)
1.24

Employees


Employees (FY)
312
Change (1Y)
−2 −0.64%
Revenue / Employee (1Y)
‪332.09 K‬ KRW
Net income / Employee (1Y)
‪8.64 K‬ KRW

About HANALL BIOPHARMA CO.,LTD


Sector
Health Technology
Headquarters
Daejeon
Founded
1973
Website
hanall.co.kr
ISIN
KR7009420001
FIGI
BBG000BG01Z0
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

009420 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 009420 is 36,300 KRW — it has decreased by −2.88% in the past 24 hours. Watch HANALL BIOPHARMA CO.,LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANALL BIOPHARMA CO.,LTD stocks are traded under the ticker 009420.
009420 stock has fallen by −13.90% compared to the previous week, the month change is a −17.26% fall, over the last year HANALL BIOPHARMA CO.,LTD has showed a 0.28% increase.
We've gathered analysts' opinions on HANALL BIOPHARMA CO.,LTD future price: according to them, 009420 price has a max estimate of 65,000.00 KRW and a min estimate of 52,000.00 KRW. Watch 009420 chart and read a more detailed HANALL BIOPHARMA CO.,LTD stock forecast: see what analysts think of HANALL BIOPHARMA CO.,LTD and suggest that you do with its stocks.
009420 reached its all-time high on Oct 22, 2024 with the price of 52,000 KRW, and its all-time low was 400 KRW and was reached on Aug 9, 2004. View more price dynamics on 009420 chart.
See other stocks reaching their highest and lowest prices.
009420 stock is 9.13% volatile and has beta coefficient of 1.24. Track HANALL BIOPHARMA CO.,LTD stock price on the chart and check out the list of the most volatile stocks — is HANALL BIOPHARMA CO.,LTD there?
Today HANALL BIOPHARMA CO.,LTD has the market capitalization of ‪1.88 T‬, it has decreased by −8.27% over the last week.
Yes, you can track HANALL BIOPHARMA CO.,LTD financials in yearly and quarterly reports right on TradingView.
HANALL BIOPHARMA CO.,LTD revenue for the last quarter amounts to ‪36.90 B‬ KRW, despite the estimated figure of ‪36.63 B‬ KRW. In the next quarter, revenue is expected to reach ‪35.60 B‬ KRW.
009420 net income for the last quarter is ‪221.93 M‬ KRW, while the quarter before that showed ‪−3.32 B‬ KRW of net income which accounts for 106.68% change. Track more HANALL BIOPHARMA CO.,LTD financial stats to get the full picture.
No, 009420 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 312.00 employees. See our rating of the largest employees — is HANALL BIOPHARMA CO.,LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANALL BIOPHARMA CO.,LTD EBITDA is ‪−3.86 B‬ KRW, and current EBITDA margin is 3.70%. See more stats in HANALL BIOPHARMA CO.,LTD financial statements.
Like other stocks, 009420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANALL BIOPHARMA CO.,LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANALL BIOPHARMA CO.,LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANALL BIOPHARMA CO.,LTD stock shows the buy signal. See more of HANALL BIOPHARMA CO.,LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.